|
1
|
Brozek JL, Bousquet J, Baena-Cagnani CE,
Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T
and Schünemann HJ: Allergic rhinitis and its impact on asthma
(ARIA) guidelines: 2010 revision. J Allergy Clin Immunol.
126:466–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y and Zhang L: Prevalence of
allergic rhinitis in China. Allergy Asthma Immunol Res. 6:105–113.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Plaut M and Valentine MD: Clinical
practice. Allergic rhinitis. N Engl J Med. 353:1934–1944. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weller PF: The immunobiology of
eosinophils. N Engl J Med. 324:1110–1118. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stone KD, Prussin C and Metcalfe DD: IgE,
mast cells, basophils, and eosinophils. J Allergy Clin Immunol.
125(2 Suppl 2): S73–S80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponath PD, Qin S, Post TW, Wang J, Wu L,
Gerard NP, Newman W, Gerard C and Mackay CR: Molecular cloning and
characterization of a human eotaxin receptor expressed selectively
on eosinophils. J Exp Med. 183:2437–2448. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sallusto F, Mackay CR and Lanzavecchia A:
Selective expression of the eotaxin receptor CCR3 by human T helper
2 cells. Science. 277:2005–2007. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fulkerson PC, Fischetti CA, McBride ML,
Hassman LM, Hogan SP and Rothenberg ME: A central regulatory role
for eosinophils and the eotaxin/CCR3 axis in chronic experimental
allergic airway inflammation. Proc Natl Acad Sci USA.
103:16418–16423. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pope SM, Zimmermann N, Stringer KF, Karow
ML and Rothenberg ME: The eotaxin chemokines and CCR3 are
fundamental regulators of allergen-induced pulmonary eosinophilia.
J Immunol. 175:5341–5350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chuang CC, Su KE, Chen CW, Fan CK, Lin FK,
Chen YS and Du WY: Anti-CCR3 monoclonal antibody inhibits
eosinophil infiltration in Angiostrongylus cantonensis-infected ICR
mice. Acta Trop. 113:209–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heath H, Qin S, Rao P, Wu L, LaRosa G,
Kassam N, Ponath PD and Mackay CR: Chemokine receptor usage by
human eosinophils. The importance of CCR3 demonstrated using an
antagonistic monoclonal antibody. J Clin Invest. 99:178–184. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
DeVincenzo JP: The promise, pitfalls and
progress of RNA-interference-based antiviral therapy for
respiratory viruses. Antivir Ther. 17:213–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karimi MH, Ebadi P, Pourfathollah AA,
Moazzeni M, Soheili ZS and Samiee S: Comparison of three techniques
for generation of tolerogenic dendritic cells: siRNA,
oligonucleotide antisense and antibody blocking. Hybridoma
(Larchmt). 29:473–480. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paddison PJ, Caudy AA, Bernstein E, Hannon
GJ and Conklin DS: Short hairpin RNAs (shRNAs) induce
sequence-specific silencing in mammalian cells. Genes Dev.
16:948–958. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rubinson DA, Dillon CP, Kwiatkowski AV,
Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus
MT, et al: A lentivirus-based system to functionally silence genes
in primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat Genet. 33:401–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dyer KD, Moser JM, Czapiga M, Siegel SJ,
Percopo CM and Rosenberg HF: Functionally competent eosinophils
differentiated ex vivo in high purity from normal mouse bone
marrow. J Immunol. 181:4004–4009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu XH, Liao B, Wang XY, Liu K and Liu YH:
Construction and identification of mouse eosinophils CCR3gene RNA
interference lentiviral vector. Zhonghua Er Bi Yan Hou Tou Jing Wai
Ke Za Zhi. 48:316–321. 2013.PubMed/NCBI
|
|
19
|
Zhu XH, Liao B, Liu K and Liu YH: Effect
of RNA interference therapy on the mice eosinophils CCR3 gene and
granule protein in the murine model of allergic rhinitis. Asian Pac
J Trop Med. 7:226–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tai PC, Sun L and Spry CJ: Effects of
IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and
IL-3 on the survival of human blood eosinophils in vitro. Clin Exp
Immunol. 85:312–316. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Coffman RL, Seymour BW, Hudak S, Jackson J
and Rennick D: Antibody to interleukin-5 inhibits helminth-induced
eosinophilia in mice. Science. 245:308–310. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cho JY, Miller M, Baek KJ, Han JW, Nayar
J, Lee SY, McElwain K, McElwain S, Friedman S and Broide DH:
Inhibition of airway remodeling in IL-5-deficient mice. J Clin
Invest. 113:551–560. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leckie MJ, ten Brinke A, Khan J, Diamant
Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF,
Djukanovic R, et al: Effects of an interleukin-5 blocking
monoclonal antibody on eosinophils, airway hyper-responsiveness,
and the late asthmatic response. Lancet. 356:2144–2148. 2000.
View Article : Google Scholar : PubMed/NCBI
|
